News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Akhil Santhosh: Strategies to improve beyond KATHERINE
Akhil Santhosh
May 9, 2025, 15:40

Akhil Santhosh: Strategies to improve beyond KATHERINE

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:

“Strategies to improve beyond KATHERINE
1. ASTEFANIA: TDM1+/-Atezolizumab
2. COMPASS HER2 RD: TDM1+/-Tucatinib
3. Destiny breast 05: TDM1 vs TdXD “

KATHERINE

More posts featuring Akhil Santhosh

Akhil Santhosh Breast Cancer cancer KATHERINE OncoDaily Oncology
Special Coverage
Blog
May 9, 2025, 15:40
Akhil Santhosh: Strategies to improve beyond KATHERINE
Blog
May 9, 2025, 15:34
Christoph Zielinski: Honored to be invited to give a talk at the 12th Meeting of Young Oncologists of Bulgaria
Blog
May 9, 2025, 15:30
Mladen Marinkovic: An Amazing week full of learning, sharing, and connecting
Blog
May 9, 2025, 15:23
Timothy Price Shares SACCaN Launch and Leadership Transition Update
Blog
May 9, 2025, 15:19
Nita Radhakrishnan: Post Graduate Institute of Child Health, Noida has been officially designated as a TIF Collaborating Centre by TIF
Blog
May 9, 2025, 15:11
Isabel Mestres: Despite everything we do, Cancer continues to touch us all, giving us no rest
Science
May 9, 2025, 15:02
Aakash Desai: New insights in BRAFV600–mutated NSCLC
Blog
May 9, 2025, 14:59
Jay Bhattacharya Congratulates Casey Means on Surgeon General Nomination
Science
May 9, 2025, 14:53
Sitna Ali Mwanzi: Navigation helps Cancer Patients Start, Continue and Complete Treatment
Insight
May 9, 2025, 14:48
Exploring PD-L1 in Oral Cavity Cancers: Insights from a Tertiary Care Audit in India - IJSO
Blog
May 9, 2025, 14:34
Maria Concetta La Milia: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy at ESTRO2025
Blog
May 9, 2025, 14:19
Josh Thomas Georgy Highlights DESTINY-Breast11 Results in High-Risk HER2+ Early Breast Cancer